Global Taletrectinib Adipate Market Growth 2026-2032
The global Taletrectinib Adipate market size is predicted to grow from US$ 44.02 million in 2025 to US$ 446 million in 2032; it is expected to grow at a CAGR of 26.8% from 2026 to 2032.
Taletrectinib Adipate is an oral, highly selective small?molecule tyrosine kinase inhibitor and a new generation of antineoplastic agent targeting ROS1 and NTRK fusion genes. It exerts potent antitumor activity by selectively inhibiting ROS1 and NTRK kinase activities, blocking downstream signaling pathways involved in tumor cell proliferation, differentiation and metastasis. It demonstrates significant inhibitory activity against crizotinib?resistant mutations such as ROS1 G2032R. It is mainly indicated for the treatment of ROS1?positive advanced or metastatic non?small cell lung cancer and NTRK fusion?positive solid tumors, characterized by strong antitumor activity, excellent central nervous system penetration and broad coverage of resistant mutationsIn 2025, global taletrectinib adipate (????????brand name Ibtrozi) production reached approximately 120,000?150,000 bottles
Taletrectinib adipate demonstrates significant market competitiveness in the global treatment of ROS1 and NTRK fusion-positive tumors owing to its excellent target selectivity, potent intracranial antitumor activity, and favorable control over drug-resistant mutations. With the popularization of precision medicine and genetic testing, the clinical demand for such targeted drugs continues to rise. By virtue of its superior efficacy and safety compared with first-generation products, taletrectinib adipate has gradually become an important option for the treatment of advanced non-small cell lung cancer and solid tumors. Driven by policy support at home and abroad, the advancement of medical insurance access, and global commercialization layout, its market coverage has been continuously expanded and patient accessibility steadily improved. The overall market shows a steady growth trend, with broad application prospects and promising market potential in both first-line and post-resistance treatment settings.
LP Information, Inc. (LPI) ' newest research report, the ?Taletrectinib Adipate Industry Forecast? looks at past sales and reviews total world Taletrectinib Adipate sales in 2025, providing a comprehensive analysis by region and market sector of projected Taletrectinib Adipate sales for 2026 through 2032. With Taletrectinib Adipate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Taletrectinib Adipate industry.
This Insight Report provides a comprehensive analysis of the global Taletrectinib Adipate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Taletrectinib Adipate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Taletrectinib Adipate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Taletrectinib Adipate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Taletrectinib Adipate.
This report presents a comprehensive overview, market shares, and growth opportunities of Taletrectinib Adipate market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Taletrectinib Adipate market?
What factors are driving Taletrectinib Adipate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Taletrectinib Adipate market opportunities vary by end market size?
How does Taletrectinib Adipate break out by Type, by Application?
Taletrectinib Adipate is an oral, highly selective small?molecule tyrosine kinase inhibitor and a new generation of antineoplastic agent targeting ROS1 and NTRK fusion genes. It exerts potent antitumor activity by selectively inhibiting ROS1 and NTRK kinase activities, blocking downstream signaling pathways involved in tumor cell proliferation, differentiation and metastasis. It demonstrates significant inhibitory activity against crizotinib?resistant mutations such as ROS1 G2032R. It is mainly indicated for the treatment of ROS1?positive advanced or metastatic non?small cell lung cancer and NTRK fusion?positive solid tumors, characterized by strong antitumor activity, excellent central nervous system penetration and broad coverage of resistant mutationsIn 2025, global taletrectinib adipate (????????brand name Ibtrozi) production reached approximately 120,000?150,000 bottles
Taletrectinib adipate demonstrates significant market competitiveness in the global treatment of ROS1 and NTRK fusion-positive tumors owing to its excellent target selectivity, potent intracranial antitumor activity, and favorable control over drug-resistant mutations. With the popularization of precision medicine and genetic testing, the clinical demand for such targeted drugs continues to rise. By virtue of its superior efficacy and safety compared with first-generation products, taletrectinib adipate has gradually become an important option for the treatment of advanced non-small cell lung cancer and solid tumors. Driven by policy support at home and abroad, the advancement of medical insurance access, and global commercialization layout, its market coverage has been continuously expanded and patient accessibility steadily improved. The overall market shows a steady growth trend, with broad application prospects and promising market potential in both first-line and post-resistance treatment settings.
LP Information, Inc. (LPI) ' newest research report, the ?Taletrectinib Adipate Industry Forecast? looks at past sales and reviews total world Taletrectinib Adipate sales in 2025, providing a comprehensive analysis by region and market sector of projected Taletrectinib Adipate sales for 2026 through 2032. With Taletrectinib Adipate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Taletrectinib Adipate industry.
This Insight Report provides a comprehensive analysis of the global Taletrectinib Adipate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Taletrectinib Adipate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Taletrectinib Adipate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Taletrectinib Adipate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Taletrectinib Adipate.
This report presents a comprehensive overview, market shares, and growth opportunities of Taletrectinib Adipate market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 33 capsules / bottle
- 30 capsules / bottle
- ROS1 Fusion Gene-Positive Adult Patients with Advanced or Metastatic Non-Small Cell Lung Cancer**
- NTRK Fusion Gene-Positive Patients with Advanced Solid Tumors**
- Hospitals
- Retail
- Online
- Original
- Generic
- Ros1 Fusion-Positive Locally Advanced
- Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AnHeart Therapeutics
- Innovent Biologics
- Asymchem Life Sciences Tianjin) C
- Daiichi Sankyo
What is the 10-year outlook for the global Taletrectinib Adipate market?
What factors are driving Taletrectinib Adipate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Taletrectinib Adipate market opportunities vary by end market size?
How does Taletrectinib Adipate break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Taletrectinib Adipate Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Taletrectinib Adipate by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Taletrectinib Adipate by Country/Region, 2021, 2025 & 2032
2.2 Taletrectinib Adipate Segment by Type
2.2.1 33 capsules / bottle
2.2.2 30 capsules / bottle
2.2.3 Taletrectinib Adipate Sales by Type
2.2.3.1 Global Taletrectinib Adipate Sales Market Share by Type (2021-2026)
2.2.3.2 Global Taletrectinib Adipate Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Taletrectinib Adipate Sale Price by Type (2021-2026)
2.3 Taletrectinib Adipate Segment by Indicated Population
2.3.1 ROS1 Fusion Gene-Positive Adult Patients with Advanced or Metastatic Non-Small Cell Lung Cancer**
2.3.2 NTRK Fusion Gene-Positive Patients with Advanced Solid Tumors**
2.3.3 Taletrectinib Adipate Sales by Indicated Population
2.3.3.1 Global Taletrectinib Adipate Sales Market Share by Indicated Population (2021-2026)
2.3.3.2 Global Taletrectinib Adipate Revenue and Market Share by Indicated Population (2021-2026)
2.3.3.3 Global Taletrectinib Adipate Sale Price by Indicated Population (2021-2026)
2.4 Taletrectinib Adipate Segment by Sales Channels
2.4.1 Hospitals
2.4.2 Retail
2.4.3 Online
2.4.4 Taletrectinib Adipate Sales by Sales Channels
2.4.4.1 Global Taletrectinib Adipate Sales Market Share by Sales Channels (2021-2026)
2.4.4.2 Global Taletrectinib Adipate Revenue and Market Share by Sales Channels (2021-2026)
2.4.4.3 Global Taletrectinib Adipate Sale Price by Sales Channels (2021-2026)
2.5 Taletrectinib Adipate Segment by Production Technology
2.5.1 Original
2.5.2 Generic
2.5.3 Taletrectinib Adipate Sales by Production Technology
2.5.3.1 Global Taletrectinib Adipate Sales Market Share by Production Technology (2021-2026)
2.5.3.2 Global Taletrectinib Adipate Revenue and Market Share by Production Technology (2021-2026)
2.5.3.3 Global Taletrectinib Adipate Sale Price by Production Technology (2021-2026)
2.6 Taletrectinib Adipate Segment by Application
2.6.1 Ros1 Fusion-Positive Locally Advanced
2.6.2 Metastatic Non-Small Cell Lung Cancer (NSCLC)
2.6.3 Others
2.6.4 Taletrectinib Adipate Sales by Application
2.6.4.1 Global Taletrectinib Adipate Sale Market Share by Application (2021-2026)
2.6.4.2 Global Taletrectinib Adipate Revenue and Market Share by Application (2021-2026)
2.6.4.3 Global Taletrectinib Adipate Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Taletrectinib Adipate Breakdown Data by Company
3.1.1 Global Taletrectinib Adipate Annual Sales by Company (2021-2026)
3.1.2 Global Taletrectinib Adipate Sales Market Share by Company (2021-2026)
3.2 Global Taletrectinib Adipate Annual Revenue by Company (2021-2026)
3.2.1 Global Taletrectinib Adipate Revenue by Company (2021-2026)
3.2.2 Global Taletrectinib Adipate Revenue Market Share by Company (2021-2026)
3.3 Global Taletrectinib Adipate Sale Price by Company
3.4 Key Manufacturers Taletrectinib Adipate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Taletrectinib Adipate Product Location Distribution
3.4.2 Players Taletrectinib Adipate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TALETRECTINIB ADIPATE BY GEOGRAPHIC REGION
4.1 World Historic Taletrectinib Adipate Market Size by Geographic Region (2021-2026)
4.1.1 Global Taletrectinib Adipate Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Taletrectinib Adipate Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Taletrectinib Adipate Market Size by Country/Region (2021-2026)
4.2.1 Global Taletrectinib Adipate Annual Sales by Country/Region (2021-2026)
4.2.2 Global Taletrectinib Adipate Annual Revenue by Country/Region (2021-2026)
4.3 Americas Taletrectinib Adipate Sales Growth
4.4 APAC Taletrectinib Adipate Sales Growth
4.5 Europe Taletrectinib Adipate Sales Growth
4.6 Middle East & Africa Taletrectinib Adipate Sales Growth
5 AMERICAS
5.1 Americas Taletrectinib Adipate Sales by Country
5.1.1 Americas Taletrectinib Adipate Sales by Country (2021-2026)
5.1.2 Americas Taletrectinib Adipate Revenue by Country (2021-2026)
5.2 Americas Taletrectinib Adipate Sales by Type (2021-2026)
5.3 Americas Taletrectinib Adipate Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Taletrectinib Adipate Sales by Region
6.1.1 APAC Taletrectinib Adipate Sales by Region (2021-2026)
6.1.2 APAC Taletrectinib Adipate Revenue by Region (2021-2026)
6.2 APAC Taletrectinib Adipate Sales by Type (2021-2026)
6.3 APAC Taletrectinib Adipate Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Taletrectinib Adipate by Country
7.1.1 Europe Taletrectinib Adipate Sales by Country (2021-2026)
7.1.2 Europe Taletrectinib Adipate Revenue by Country (2021-2026)
7.2 Europe Taletrectinib Adipate Sales by Type (2021-2026)
7.3 Europe Taletrectinib Adipate Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Taletrectinib Adipate by Country
8.1.1 Middle East & Africa Taletrectinib Adipate Sales by Country (2021-2026)
8.1.2 Middle East & Africa Taletrectinib Adipate Revenue by Country (2021-2026)
8.2 Middle East & Africa Taletrectinib Adipate Sales by Type (2021-2026)
8.3 Middle East & Africa Taletrectinib Adipate Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Taletrectinib Adipate
10.3 Manufacturing Process Analysis of Taletrectinib Adipate
10.4 Industry Chain Structure of Taletrectinib Adipate
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Taletrectinib Adipate Distributors
11.3 Taletrectinib Adipate Customer
12 WORLD FORECAST REVIEW FOR TALETRECTINIB ADIPATE BY GEOGRAPHIC REGION
12.1 Global Taletrectinib Adipate Market Size Forecast by Region
12.1.1 Global Taletrectinib Adipate Forecast by Region (2027-2032)
12.1.2 Global Taletrectinib Adipate Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Taletrectinib Adipate Forecast by Type (2027-2032)
12.7 Global Taletrectinib Adipate Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 AnHeart Therapeutics
13.1.1 AnHeart Therapeutics Company Information
13.1.2 AnHeart Therapeutics Taletrectinib Adipate Product Portfolios and Specifications
13.1.3 AnHeart Therapeutics Taletrectinib Adipate Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 AnHeart Therapeutics Main Business Overview
13.1.5 AnHeart Therapeutics Latest Developments
13.2 Innovent Biologics
13.2.1 Innovent Biologics Company Information
13.2.2 Innovent Biologics Taletrectinib Adipate Product Portfolios and Specifications
13.2.3 Innovent Biologics Taletrectinib Adipate Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Innovent Biologics Main Business Overview
13.2.5 Innovent Biologics Latest Developments
13.3 Asymchem Life Sciences Tianjin) C
13.3.1 Asymchem Life Sciences Tianjin) C Company Information
13.3.2 Asymchem Life Sciences Tianjin) C Taletrectinib Adipate Product Portfolios and Specifications
13.3.3 Asymchem Life Sciences Tianjin) C Taletrectinib Adipate Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Asymchem Life Sciences Tianjin) C Main Business Overview
13.3.5 Asymchem Life Sciences Tianjin) C Latest Developments
13.4 Daiichi Sankyo
13.4.1 Daiichi Sankyo Company Information
13.4.2 Daiichi Sankyo Taletrectinib Adipate Product Portfolios and Specifications
13.4.3 Daiichi Sankyo Taletrectinib Adipate Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Daiichi Sankyo Main Business Overview
13.4.5 Daiichi Sankyo Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Taletrectinib Adipate Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Taletrectinib Adipate by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Taletrectinib Adipate by Country/Region, 2021, 2025 & 2032
2.2 Taletrectinib Adipate Segment by Type
2.2.1 33 capsules / bottle
2.2.2 30 capsules / bottle
2.2.3 Taletrectinib Adipate Sales by Type
2.2.3.1 Global Taletrectinib Adipate Sales Market Share by Type (2021-2026)
2.2.3.2 Global Taletrectinib Adipate Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Taletrectinib Adipate Sale Price by Type (2021-2026)
2.3 Taletrectinib Adipate Segment by Indicated Population
2.3.1 ROS1 Fusion Gene-Positive Adult Patients with Advanced or Metastatic Non-Small Cell Lung Cancer**
2.3.2 NTRK Fusion Gene-Positive Patients with Advanced Solid Tumors**
2.3.3 Taletrectinib Adipate Sales by Indicated Population
2.3.3.1 Global Taletrectinib Adipate Sales Market Share by Indicated Population (2021-2026)
2.3.3.2 Global Taletrectinib Adipate Revenue and Market Share by Indicated Population (2021-2026)
2.3.3.3 Global Taletrectinib Adipate Sale Price by Indicated Population (2021-2026)
2.4 Taletrectinib Adipate Segment by Sales Channels
2.4.1 Hospitals
2.4.2 Retail
2.4.3 Online
2.4.4 Taletrectinib Adipate Sales by Sales Channels
2.4.4.1 Global Taletrectinib Adipate Sales Market Share by Sales Channels (2021-2026)
2.4.4.2 Global Taletrectinib Adipate Revenue and Market Share by Sales Channels (2021-2026)
2.4.4.3 Global Taletrectinib Adipate Sale Price by Sales Channels (2021-2026)
2.5 Taletrectinib Adipate Segment by Production Technology
2.5.1 Original
2.5.2 Generic
2.5.3 Taletrectinib Adipate Sales by Production Technology
2.5.3.1 Global Taletrectinib Adipate Sales Market Share by Production Technology (2021-2026)
2.5.3.2 Global Taletrectinib Adipate Revenue and Market Share by Production Technology (2021-2026)
2.5.3.3 Global Taletrectinib Adipate Sale Price by Production Technology (2021-2026)
2.6 Taletrectinib Adipate Segment by Application
2.6.1 Ros1 Fusion-Positive Locally Advanced
2.6.2 Metastatic Non-Small Cell Lung Cancer (NSCLC)
2.6.3 Others
2.6.4 Taletrectinib Adipate Sales by Application
2.6.4.1 Global Taletrectinib Adipate Sale Market Share by Application (2021-2026)
2.6.4.2 Global Taletrectinib Adipate Revenue and Market Share by Application (2021-2026)
2.6.4.3 Global Taletrectinib Adipate Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Taletrectinib Adipate Breakdown Data by Company
3.1.1 Global Taletrectinib Adipate Annual Sales by Company (2021-2026)
3.1.2 Global Taletrectinib Adipate Sales Market Share by Company (2021-2026)
3.2 Global Taletrectinib Adipate Annual Revenue by Company (2021-2026)
3.2.1 Global Taletrectinib Adipate Revenue by Company (2021-2026)
3.2.2 Global Taletrectinib Adipate Revenue Market Share by Company (2021-2026)
3.3 Global Taletrectinib Adipate Sale Price by Company
3.4 Key Manufacturers Taletrectinib Adipate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Taletrectinib Adipate Product Location Distribution
3.4.2 Players Taletrectinib Adipate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TALETRECTINIB ADIPATE BY GEOGRAPHIC REGION
4.1 World Historic Taletrectinib Adipate Market Size by Geographic Region (2021-2026)
4.1.1 Global Taletrectinib Adipate Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Taletrectinib Adipate Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Taletrectinib Adipate Market Size by Country/Region (2021-2026)
4.2.1 Global Taletrectinib Adipate Annual Sales by Country/Region (2021-2026)
4.2.2 Global Taletrectinib Adipate Annual Revenue by Country/Region (2021-2026)
4.3 Americas Taletrectinib Adipate Sales Growth
4.4 APAC Taletrectinib Adipate Sales Growth
4.5 Europe Taletrectinib Adipate Sales Growth
4.6 Middle East & Africa Taletrectinib Adipate Sales Growth
5 AMERICAS
5.1 Americas Taletrectinib Adipate Sales by Country
5.1.1 Americas Taletrectinib Adipate Sales by Country (2021-2026)
5.1.2 Americas Taletrectinib Adipate Revenue by Country (2021-2026)
5.2 Americas Taletrectinib Adipate Sales by Type (2021-2026)
5.3 Americas Taletrectinib Adipate Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Taletrectinib Adipate Sales by Region
6.1.1 APAC Taletrectinib Adipate Sales by Region (2021-2026)
6.1.2 APAC Taletrectinib Adipate Revenue by Region (2021-2026)
6.2 APAC Taletrectinib Adipate Sales by Type (2021-2026)
6.3 APAC Taletrectinib Adipate Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Taletrectinib Adipate by Country
7.1.1 Europe Taletrectinib Adipate Sales by Country (2021-2026)
7.1.2 Europe Taletrectinib Adipate Revenue by Country (2021-2026)
7.2 Europe Taletrectinib Adipate Sales by Type (2021-2026)
7.3 Europe Taletrectinib Adipate Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Taletrectinib Adipate by Country
8.1.1 Middle East & Africa Taletrectinib Adipate Sales by Country (2021-2026)
8.1.2 Middle East & Africa Taletrectinib Adipate Revenue by Country (2021-2026)
8.2 Middle East & Africa Taletrectinib Adipate Sales by Type (2021-2026)
8.3 Middle East & Africa Taletrectinib Adipate Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Taletrectinib Adipate
10.3 Manufacturing Process Analysis of Taletrectinib Adipate
10.4 Industry Chain Structure of Taletrectinib Adipate
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Taletrectinib Adipate Distributors
11.3 Taletrectinib Adipate Customer
12 WORLD FORECAST REVIEW FOR TALETRECTINIB ADIPATE BY GEOGRAPHIC REGION
12.1 Global Taletrectinib Adipate Market Size Forecast by Region
12.1.1 Global Taletrectinib Adipate Forecast by Region (2027-2032)
12.1.2 Global Taletrectinib Adipate Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Taletrectinib Adipate Forecast by Type (2027-2032)
12.7 Global Taletrectinib Adipate Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 AnHeart Therapeutics
13.1.1 AnHeart Therapeutics Company Information
13.1.2 AnHeart Therapeutics Taletrectinib Adipate Product Portfolios and Specifications
13.1.3 AnHeart Therapeutics Taletrectinib Adipate Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 AnHeart Therapeutics Main Business Overview
13.1.5 AnHeart Therapeutics Latest Developments
13.2 Innovent Biologics
13.2.1 Innovent Biologics Company Information
13.2.2 Innovent Biologics Taletrectinib Adipate Product Portfolios and Specifications
13.2.3 Innovent Biologics Taletrectinib Adipate Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Innovent Biologics Main Business Overview
13.2.5 Innovent Biologics Latest Developments
13.3 Asymchem Life Sciences Tianjin) C
13.3.1 Asymchem Life Sciences Tianjin) C Company Information
13.3.2 Asymchem Life Sciences Tianjin) C Taletrectinib Adipate Product Portfolios and Specifications
13.3.3 Asymchem Life Sciences Tianjin) C Taletrectinib Adipate Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Asymchem Life Sciences Tianjin) C Main Business Overview
13.3.5 Asymchem Life Sciences Tianjin) C Latest Developments
13.4 Daiichi Sankyo
13.4.1 Daiichi Sankyo Company Information
13.4.2 Daiichi Sankyo Taletrectinib Adipate Product Portfolios and Specifications
13.4.3 Daiichi Sankyo Taletrectinib Adipate Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Daiichi Sankyo Main Business Overview
13.4.5 Daiichi Sankyo Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Taletrectinib Adipate Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Taletrectinib Adipate Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 33 capsules / bottle
Table 4. Major Players of 30 capsules / bottle
Table 5. Global Taletrectinib Adipate Sales by Type (2021-2026) & (Units)
Table 6. Global Taletrectinib Adipate Sales Market Share by Type (2021-2026)
Table 7. Global Taletrectinib Adipate Revenue by Type (2021-2026) & ($ million)
Table 8. Global Taletrectinib Adipate Revenue Market Share by Type (2021-2026)
Table 9. Global Taletrectinib Adipate Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of ROS1 Fusion Gene-Positive Adult Patients with Advanced or Metastatic Non-Small Cell Lung Cancer**
Table 11. Major Players of NTRK Fusion Gene-Positive Patients with Advanced Solid Tumors**
Table 12. Global Taletrectinib Adipate Sales by Indicated Population (2021-2026) & (Units)
Table 13. Global Taletrectinib Adipate Sales Market Share by Indicated Population (2021-2026)
Table 14. Global Taletrectinib Adipate Revenue by Indicated Population (2021-2026) & ($ million)
Table 15. Global Taletrectinib Adipate Revenue Market Share by Indicated Population (2021-2026)
Table 16. Global Taletrectinib Adipate Sale Price by Indicated Population (2021-2026) & (US$/Unit)
Table 17. Major Players of Hospitals
Table 18. Major Players of Retail
Table 19. Major Players of Online
Table 20. Global Taletrectinib Adipate Sales by Sales Channels (2021-2026) & (Units)
Table 21. Global Taletrectinib Adipate Sales Market Share by Sales Channels (2021-2026)
Table 22. Global Taletrectinib Adipate Revenue by Sales Channels (2021-2026) & ($ million)
Table 23. Global Taletrectinib Adipate Revenue Market Share by Sales Channels (2021-2026)
Table 24. Global Taletrectinib Adipate Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 25. Major Players of Original
Table 26. Major Players of Generic
Table 27. Global Taletrectinib Adipate Sales by Production Technology (2021-2026) & (Units)
Table 28. Global Taletrectinib Adipate Sales Market Share by Production Technology (2021-2026)
Table 29. Global Taletrectinib Adipate Revenue by Production Technology (2021-2026) & ($ million)
Table 30. Global Taletrectinib Adipate Revenue Market Share by Production Technology (2021-2026)
Table 31. Global Taletrectinib Adipate Sale Price by Production Technology (2021-2026) & (US$/Unit)
Table 32. Global Taletrectinib Adipate Sale by Application (2021-2026) & (Units)
Table 33. Global Taletrectinib Adipate Sale Market Share by Application (2021-2026)
Table 34. Global Taletrectinib Adipate Revenue by Application (2021-2026) & ($ million)
Table 35. Global Taletrectinib Adipate Revenue Market Share by Application (2021-2026)
Table 36. Global Taletrectinib Adipate Sale Price by Application (2021-2026) & (US$/Unit)
Table 37. Global Taletrectinib Adipate Sales by Company (2021-2026) & (Units)
Table 38. Global Taletrectinib Adipate Sales Market Share by Company (2021-2026)
Table 39. Global Taletrectinib Adipate Revenue by Company (2021-2026) & ($ millions)
Table 40. Global Taletrectinib Adipate Revenue Market Share by Company (2021-2026)
Table 41. Global Taletrectinib Adipate Sale Price by Company (2021-2026) & (US$/Unit)
Table 42. Key Manufacturers Taletrectinib Adipate Producing Area Distribution and Sales Area
Table 43. Players Taletrectinib Adipate Products Offered
Table 44. Taletrectinib Adipate Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Market M&A Activity & Strategy
Table 47. Global Taletrectinib Adipate Sales by Geographic Region (2021-2026) & (Units)
Table 48. Global Taletrectinib Adipate Sales Market Share Geographic Region (2021-2026)
Table 49. Global Taletrectinib Adipate Revenue by Geographic Region (2021-2026) & ($ millions)
Table 50. Global Taletrectinib Adipate Revenue Market Share by Geographic Region (2021-2026)
Table 51. Global Taletrectinib Adipate Sales by Country/Region (2021-2026) & (Units)
Table 52. Global Taletrectinib Adipate Sales Market Share by Country/Region (2021-2026)
Table 53. Global Taletrectinib Adipate Revenue by Country/Region (2021-2026) & ($ millions)
Table 54. Global Taletrectinib Adipate Revenue Market Share by Country/Region (2021-2026)
Table 55. Americas Taletrectinib Adipate Sales by Country (2021-2026) & (Units)
Table 56. Americas Taletrectinib Adipate Sales Market Share by Country (2021-2026)
Table 57. Americas Taletrectinib Adipate Revenue by Country (2021-2026) & ($ millions)
Table 58. Americas Taletrectinib Adipate Sales by Type (2021-2026) & (Units)
Table 59. Americas Taletrectinib Adipate Sales by Application (2021-2026) & (Units)
Table 60. APAC Taletrectinib Adipate Sales by Region (2021-2026) & (Units)
Table 61. APAC Taletrectinib Adipate Sales Market Share by Region (2021-2026)
Table 62. APAC Taletrectinib Adipate Revenue by Region (2021-2026) & ($ millions)
Table 63. APAC Taletrectinib Adipate Sales by Type (2021-2026) & (Units)
Table 64. APAC Taletrectinib Adipate Sales by Application (2021-2026) & (Units)
Table 65. Europe Taletrectinib Adipate Sales by Country (2021-2026) & (Units)
Table 66. Europe Taletrectinib Adipate Revenue by Country (2021-2026) & ($ millions)
Table 67. Europe Taletrectinib Adipate Sales by Type (2021-2026) & (Units)
Table 68. Europe Taletrectinib Adipate Sales by Application (2021-2026) & (Units)
Table 69. Middle East & Africa Taletrectinib Adipate Sales by Country (2021-2026) & (Units)
Table 70. Middle East & Africa Taletrectinib Adipate Revenue Market Share by Country (2021-2026)
Table 71. Middle East & Africa Taletrectinib Adipate Sales by Type (2021-2026) & (Units)
Table 72. Middle East & Africa Taletrectinib Adipate Sales by Application (2021-2026) & (Units)
Table 73. Key Market Drivers & Growth Opportunities of Taletrectinib Adipate
Table 74. Key Market Challenges & Risks of Taletrectinib Adipate
Table 75. Key Industry Trends of Taletrectinib Adipate
Table 76. Taletrectinib Adipate Raw Material
Table 77. Key Suppliers of Raw Materials
Table 78. Taletrectinib Adipate Distributors List
Table 79. Taletrectinib Adipate Customer List
Table 80. Global Taletrectinib Adipate Sales Forecast by Region (2027-2032) & (Units)
Table 81. Global Taletrectinib Adipate Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Americas Taletrectinib Adipate Sales Forecast by Country (2027-2032) & (Units)
Table 83. Americas Taletrectinib Adipate Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. APAC Taletrectinib Adipate Sales Forecast by Region (2027-2032) & (Units)
Table 85. APAC Taletrectinib Adipate Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Europe Taletrectinib Adipate Sales Forecast by Country (2027-2032) & (Units)
Table 87. Europe Taletrectinib Adipate Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Middle East & Africa Taletrectinib Adipate Sales Forecast by Country (2027-2032) & (Units)
Table 89. Middle East & Africa Taletrectinib Adipate Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Global Taletrectinib Adipate Sales Forecast by Type (2027-2032) & (Units)
Table 91. Global Taletrectinib Adipate Revenue Forecast by Type (2027-2032) & ($ millions)
Table 92. Global Taletrectinib Adipate Sales Forecast by Application (2027-2032) & (Units)
Table 93. Global Taletrectinib Adipate Revenue Forecast by Application (2027-2032) & ($ millions)
Table 94. AnHeart Therapeutics Basic Information, Taletrectinib Adipate Manufacturing Base, Sales Area and Its Competitors
Table 95. AnHeart Therapeutics Taletrectinib Adipate Product Portfolios and Specifications
Table 96. AnHeart Therapeutics Taletrectinib Adipate Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. AnHeart Therapeutics Main Business
Table 98. AnHeart Therapeutics Latest Developments
Table 99. Innovent Biologics Basic Information, Taletrectinib Adipate Manufacturing Base, Sales Area and Its Competitors
Table 100. Innovent Biologics Taletrectinib Adipate Product Portfolios and Specifications
Table 101. Innovent Biologics Taletrectinib Adipate Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Innovent Biologics Main Business
Table 103. Innovent Biologics Latest Developments
Table 104. Asymchem Life Sciences Tianjin) C Basic Information, Taletrectinib Adipate Manufacturing Base, Sales Area and Its Competitors
Table 105. Asymchem Life Sciences Tianjin) C Taletrectinib Adipate Product Portfolios and Specifications
Table 106. Asymchem Life Sciences Tianjin) C Taletrectinib Adipate Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Asymchem Life Sciences Tianjin) C Main Business
Table 108. Asymchem Life Sciences Tianjin) C Latest Developments
Table 109. Daiichi Sankyo Basic Information, Taletrectinib Adipate Manufacturing Base, Sales Area and Its Competitors
Table 110. Daiichi Sankyo Taletrectinib Adipate Product Portfolios and Specifications
Table 111. Daiichi Sankyo Taletrectinib Adipate Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Daiichi Sankyo Main Business
Table 113. Daiichi Sankyo Latest Developments
Table 1. Taletrectinib Adipate Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Taletrectinib Adipate Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 33 capsules / bottle
Table 4. Major Players of 30 capsules / bottle
Table 5. Global Taletrectinib Adipate Sales by Type (2021-2026) & (Units)
Table 6. Global Taletrectinib Adipate Sales Market Share by Type (2021-2026)
Table 7. Global Taletrectinib Adipate Revenue by Type (2021-2026) & ($ million)
Table 8. Global Taletrectinib Adipate Revenue Market Share by Type (2021-2026)
Table 9. Global Taletrectinib Adipate Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of ROS1 Fusion Gene-Positive Adult Patients with Advanced or Metastatic Non-Small Cell Lung Cancer**
Table 11. Major Players of NTRK Fusion Gene-Positive Patients with Advanced Solid Tumors**
Table 12. Global Taletrectinib Adipate Sales by Indicated Population (2021-2026) & (Units)
Table 13. Global Taletrectinib Adipate Sales Market Share by Indicated Population (2021-2026)
Table 14. Global Taletrectinib Adipate Revenue by Indicated Population (2021-2026) & ($ million)
Table 15. Global Taletrectinib Adipate Revenue Market Share by Indicated Population (2021-2026)
Table 16. Global Taletrectinib Adipate Sale Price by Indicated Population (2021-2026) & (US$/Unit)
Table 17. Major Players of Hospitals
Table 18. Major Players of Retail
Table 19. Major Players of Online
Table 20. Global Taletrectinib Adipate Sales by Sales Channels (2021-2026) & (Units)
Table 21. Global Taletrectinib Adipate Sales Market Share by Sales Channels (2021-2026)
Table 22. Global Taletrectinib Adipate Revenue by Sales Channels (2021-2026) & ($ million)
Table 23. Global Taletrectinib Adipate Revenue Market Share by Sales Channels (2021-2026)
Table 24. Global Taletrectinib Adipate Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 25. Major Players of Original
Table 26. Major Players of Generic
Table 27. Global Taletrectinib Adipate Sales by Production Technology (2021-2026) & (Units)
Table 28. Global Taletrectinib Adipate Sales Market Share by Production Technology (2021-2026)
Table 29. Global Taletrectinib Adipate Revenue by Production Technology (2021-2026) & ($ million)
Table 30. Global Taletrectinib Adipate Revenue Market Share by Production Technology (2021-2026)
Table 31. Global Taletrectinib Adipate Sale Price by Production Technology (2021-2026) & (US$/Unit)
Table 32. Global Taletrectinib Adipate Sale by Application (2021-2026) & (Units)
Table 33. Global Taletrectinib Adipate Sale Market Share by Application (2021-2026)
Table 34. Global Taletrectinib Adipate Revenue by Application (2021-2026) & ($ million)
Table 35. Global Taletrectinib Adipate Revenue Market Share by Application (2021-2026)
Table 36. Global Taletrectinib Adipate Sale Price by Application (2021-2026) & (US$/Unit)
Table 37. Global Taletrectinib Adipate Sales by Company (2021-2026) & (Units)
Table 38. Global Taletrectinib Adipate Sales Market Share by Company (2021-2026)
Table 39. Global Taletrectinib Adipate Revenue by Company (2021-2026) & ($ millions)
Table 40. Global Taletrectinib Adipate Revenue Market Share by Company (2021-2026)
Table 41. Global Taletrectinib Adipate Sale Price by Company (2021-2026) & (US$/Unit)
Table 42. Key Manufacturers Taletrectinib Adipate Producing Area Distribution and Sales Area
Table 43. Players Taletrectinib Adipate Products Offered
Table 44. Taletrectinib Adipate Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Market M&A Activity & Strategy
Table 47. Global Taletrectinib Adipate Sales by Geographic Region (2021-2026) & (Units)
Table 48. Global Taletrectinib Adipate Sales Market Share Geographic Region (2021-2026)
Table 49. Global Taletrectinib Adipate Revenue by Geographic Region (2021-2026) & ($ millions)
Table 50. Global Taletrectinib Adipate Revenue Market Share by Geographic Region (2021-2026)
Table 51. Global Taletrectinib Adipate Sales by Country/Region (2021-2026) & (Units)
Table 52. Global Taletrectinib Adipate Sales Market Share by Country/Region (2021-2026)
Table 53. Global Taletrectinib Adipate Revenue by Country/Region (2021-2026) & ($ millions)
Table 54. Global Taletrectinib Adipate Revenue Market Share by Country/Region (2021-2026)
Table 55. Americas Taletrectinib Adipate Sales by Country (2021-2026) & (Units)
Table 56. Americas Taletrectinib Adipate Sales Market Share by Country (2021-2026)
Table 57. Americas Taletrectinib Adipate Revenue by Country (2021-2026) & ($ millions)
Table 58. Americas Taletrectinib Adipate Sales by Type (2021-2026) & (Units)
Table 59. Americas Taletrectinib Adipate Sales by Application (2021-2026) & (Units)
Table 60. APAC Taletrectinib Adipate Sales by Region (2021-2026) & (Units)
Table 61. APAC Taletrectinib Adipate Sales Market Share by Region (2021-2026)
Table 62. APAC Taletrectinib Adipate Revenue by Region (2021-2026) & ($ millions)
Table 63. APAC Taletrectinib Adipate Sales by Type (2021-2026) & (Units)
Table 64. APAC Taletrectinib Adipate Sales by Application (2021-2026) & (Units)
Table 65. Europe Taletrectinib Adipate Sales by Country (2021-2026) & (Units)
Table 66. Europe Taletrectinib Adipate Revenue by Country (2021-2026) & ($ millions)
Table 67. Europe Taletrectinib Adipate Sales by Type (2021-2026) & (Units)
Table 68. Europe Taletrectinib Adipate Sales by Application (2021-2026) & (Units)
Table 69. Middle East & Africa Taletrectinib Adipate Sales by Country (2021-2026) & (Units)
Table 70. Middle East & Africa Taletrectinib Adipate Revenue Market Share by Country (2021-2026)
Table 71. Middle East & Africa Taletrectinib Adipate Sales by Type (2021-2026) & (Units)
Table 72. Middle East & Africa Taletrectinib Adipate Sales by Application (2021-2026) & (Units)
Table 73. Key Market Drivers & Growth Opportunities of Taletrectinib Adipate
Table 74. Key Market Challenges & Risks of Taletrectinib Adipate
Table 75. Key Industry Trends of Taletrectinib Adipate
Table 76. Taletrectinib Adipate Raw Material
Table 77. Key Suppliers of Raw Materials
Table 78. Taletrectinib Adipate Distributors List
Table 79. Taletrectinib Adipate Customer List
Table 80. Global Taletrectinib Adipate Sales Forecast by Region (2027-2032) & (Units)
Table 81. Global Taletrectinib Adipate Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Americas Taletrectinib Adipate Sales Forecast by Country (2027-2032) & (Units)
Table 83. Americas Taletrectinib Adipate Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. APAC Taletrectinib Adipate Sales Forecast by Region (2027-2032) & (Units)
Table 85. APAC Taletrectinib Adipate Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Europe Taletrectinib Adipate Sales Forecast by Country (2027-2032) & (Units)
Table 87. Europe Taletrectinib Adipate Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Middle East & Africa Taletrectinib Adipate Sales Forecast by Country (2027-2032) & (Units)
Table 89. Middle East & Africa Taletrectinib Adipate Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Global Taletrectinib Adipate Sales Forecast by Type (2027-2032) & (Units)
Table 91. Global Taletrectinib Adipate Revenue Forecast by Type (2027-2032) & ($ millions)
Table 92. Global Taletrectinib Adipate Sales Forecast by Application (2027-2032) & (Units)
Table 93. Global Taletrectinib Adipate Revenue Forecast by Application (2027-2032) & ($ millions)
Table 94. AnHeart Therapeutics Basic Information, Taletrectinib Adipate Manufacturing Base, Sales Area and Its Competitors
Table 95. AnHeart Therapeutics Taletrectinib Adipate Product Portfolios and Specifications
Table 96. AnHeart Therapeutics Taletrectinib Adipate Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. AnHeart Therapeutics Main Business
Table 98. AnHeart Therapeutics Latest Developments
Table 99. Innovent Biologics Basic Information, Taletrectinib Adipate Manufacturing Base, Sales Area and Its Competitors
Table 100. Innovent Biologics Taletrectinib Adipate Product Portfolios and Specifications
Table 101. Innovent Biologics Taletrectinib Adipate Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Innovent Biologics Main Business
Table 103. Innovent Biologics Latest Developments
Table 104. Asymchem Life Sciences Tianjin) C Basic Information, Taletrectinib Adipate Manufacturing Base, Sales Area and Its Competitors
Table 105. Asymchem Life Sciences Tianjin) C Taletrectinib Adipate Product Portfolios and Specifications
Table 106. Asymchem Life Sciences Tianjin) C Taletrectinib Adipate Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Asymchem Life Sciences Tianjin) C Main Business
Table 108. Asymchem Life Sciences Tianjin) C Latest Developments
Table 109. Daiichi Sankyo Basic Information, Taletrectinib Adipate Manufacturing Base, Sales Area and Its Competitors
Table 110. Daiichi Sankyo Taletrectinib Adipate Product Portfolios and Specifications
Table 111. Daiichi Sankyo Taletrectinib Adipate Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Daiichi Sankyo Main Business
Table 113. Daiichi Sankyo Latest Developments
LIST OF FIGURES
Figure 1. Picture of Taletrectinib Adipate
Figure 2. Taletrectinib Adipate Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Taletrectinib Adipate Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Taletrectinib Adipate Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Taletrectinib Adipate Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Taletrectinib Adipate Sales Market Share by Country/Region (2025)
Figure 10. Taletrectinib Adipate Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 33 capsules / bottle
Figure 12. Product Picture of 30 capsules / bottle
Figure 13. Global Taletrectinib Adipate Sales Market Share by Type in 2026
Figure 14. Global Taletrectinib Adipate Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of ROS1 Fusion Gene-Positive Adult Patients with Advanced or Metastatic Non-Small Cell Lung Cancer**
Figure 16. Product Picture of NTRK Fusion Gene-Positive Patients with Advanced Solid Tumors**
Figure 17. Global Taletrectinib Adipate Sales Market Share by Indicated Population in 2026
Figure 18. Global Taletrectinib Adipate Revenue Market Share by Indicated Population (2021-2026)
Figure 19. Product Picture of Hospitals
Figure 20. Product Picture of Retail
Figure 21. Product Picture of Online
Figure 22. Global Taletrectinib Adipate Sales Market Share by Sales Channels in 2026
Figure 23. Global Taletrectinib Adipate Revenue Market Share by Sales Channels (2021-2026)
Figure 24. Product Picture of Original
Figure 25. Product Picture of Generic
Figure 26. Global Taletrectinib Adipate Sales Market Share by Production Technology in 2026
Figure 27. Global Taletrectinib Adipate Revenue Market Share by Production Technology (2021-2026)
Figure 28. Taletrectinib Adipate Consumed in Ros1 Fusion-Positive Locally Advanced
Figure 29. Global Taletrectinib Adipate Market: Ros1 Fusion-Positive Locally Advanced (2021-2026) & (Units)
Figure 30. Taletrectinib Adipate Consumed in Metastatic Non-Small Cell Lung Cancer (NSCLC)
Figure 31. Global Taletrectinib Adipate Market: Metastatic Non-Small Cell Lung Cancer (NSCLC) (2021-2026) & (Units)
Figure 32. Taletrectinib Adipate Consumed in Others
Figure 33. Global Taletrectinib Adipate Market: Others (2021-2026) & (Units)
Figure 34. Global Taletrectinib Adipate Sale Market Share by Application (2025)
Figure 35. Global Taletrectinib Adipate Revenue Market Share by Application in 2025
Figure 36. Taletrectinib Adipate Sales by Company in 2025 (Units)
Figure 37. Global Taletrectinib Adipate Sales Market Share by Company in 2025
Figure 38. Taletrectinib Adipate Revenue by Company in 2025 ($ millions)
Figure 39. Global Taletrectinib Adipate Revenue Market Share by Company in 2025
Figure 40. Global Taletrectinib Adipate Sales Market Share by Geographic Region (2021-2026)
Figure 41. Global Taletrectinib Adipate Revenue Market Share by Geographic Region in 2025
Figure 42. Americas Taletrectinib Adipate Sales 2021-2026 (Units)
Figure 43. Americas Taletrectinib Adipate Revenue 2021-2026 ($ millions)
Figure 44. APAC Taletrectinib Adipate Sales 2021-2026 (Units)
Figure 45. APAC Taletrectinib Adipate Revenue 2021-2026 ($ millions)
Figure 46. Europe Taletrectinib Adipate Sales 2021-2026 (Units)
Figure 47. Europe Taletrectinib Adipate Revenue 2021-2026 ($ millions)
Figure 48. Middle East & Africa Taletrectinib Adipate Sales 2021-2026 (Units)
Figure 49. Middle East & Africa Taletrectinib Adipate Revenue 2021-2026 ($ millions)
Figure 50. Americas Taletrectinib Adipate Sales Market Share by Country in 2025
Figure 51. Americas Taletrectinib Adipate Revenue Market Share by Country (2021-2026)
Figure 52. Americas Taletrectinib Adipate Sales Market Share by Type (2021-2026)
Figure 53. Americas Taletrectinib Adipate Sales Market Share by Application (2021-2026)
Figure 54. United States Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 55. Canada Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 56. Mexico Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 57. Brazil Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 58. APAC Taletrectinib Adipate Sales Market Share by Region in 2025
Figure 59. APAC Taletrectinib Adipate Revenue Market Share by Region (2021-2026)
Figure 60. APAC Taletrectinib Adipate Sales Market Share by Type (2021-2026)
Figure 61. APAC Taletrectinib Adipate Sales Market Share by Application (2021-2026)
Figure 62. China Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 63. Japan Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 64. South Korea Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 65. Southeast Asia Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 66. India Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 67. Australia Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 68. China Taiwan Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 69. Europe Taletrectinib Adipate Sales Market Share by Country in 2025
Figure 70. Europe Taletrectinib Adipate Revenue Market Share by Country (2021-2026)
Figure 71. Europe Taletrectinib Adipate Sales Market Share by Type (2021-2026)
Figure 72. Europe Taletrectinib Adipate Sales Market Share by Application (2021-2026)
Figure 73. Germany Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 74. France Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 75. UK Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 76. Italy Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 77. Russia Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 78. Middle East & Africa Taletrectinib Adipate Sales Market Share by Country (2021-2026)
Figure 79. Middle East & Africa Taletrectinib Adipate Sales Market Share by Type (2021-2026)
Figure 80. Middle East & Africa Taletrectinib Adipate Sales Market Share by Application (2021-2026)
Figure 81. Egypt Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 82. South Africa Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 83. Israel Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 84. Turkey Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 85. GCC Countries Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of Taletrectinib Adipate in 2026
Figure 87. Manufacturing Process Analysis of Taletrectinib Adipate
Figure 88. Industry Chain Structure of Taletrectinib Adipate
Figure 89. Channels of Distribution
Figure 90. Global Taletrectinib Adipate Sales Market Forecast by Region (2027-2032)
Figure 91. Global Taletrectinib Adipate Revenue Market Share Forecast by Region (2027-2032)
Figure 92. Global Taletrectinib Adipate Sales Market Share Forecast by Type (2027-2032)
Figure 93. Global Taletrectinib Adipate Revenue Market Share Forecast by Type (2027-2032)
Figure 94. Global Taletrectinib Adipate Sales Market Share Forecast by Application (2027-2032)
Figure 95. Global Taletrectinib Adipate Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Taletrectinib Adipate
Figure 2. Taletrectinib Adipate Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Taletrectinib Adipate Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Taletrectinib Adipate Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Taletrectinib Adipate Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Taletrectinib Adipate Sales Market Share by Country/Region (2025)
Figure 10. Taletrectinib Adipate Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 33 capsules / bottle
Figure 12. Product Picture of 30 capsules / bottle
Figure 13. Global Taletrectinib Adipate Sales Market Share by Type in 2026
Figure 14. Global Taletrectinib Adipate Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of ROS1 Fusion Gene-Positive Adult Patients with Advanced or Metastatic Non-Small Cell Lung Cancer**
Figure 16. Product Picture of NTRK Fusion Gene-Positive Patients with Advanced Solid Tumors**
Figure 17. Global Taletrectinib Adipate Sales Market Share by Indicated Population in 2026
Figure 18. Global Taletrectinib Adipate Revenue Market Share by Indicated Population (2021-2026)
Figure 19. Product Picture of Hospitals
Figure 20. Product Picture of Retail
Figure 21. Product Picture of Online
Figure 22. Global Taletrectinib Adipate Sales Market Share by Sales Channels in 2026
Figure 23. Global Taletrectinib Adipate Revenue Market Share by Sales Channels (2021-2026)
Figure 24. Product Picture of Original
Figure 25. Product Picture of Generic
Figure 26. Global Taletrectinib Adipate Sales Market Share by Production Technology in 2026
Figure 27. Global Taletrectinib Adipate Revenue Market Share by Production Technology (2021-2026)
Figure 28. Taletrectinib Adipate Consumed in Ros1 Fusion-Positive Locally Advanced
Figure 29. Global Taletrectinib Adipate Market: Ros1 Fusion-Positive Locally Advanced (2021-2026) & (Units)
Figure 30. Taletrectinib Adipate Consumed in Metastatic Non-Small Cell Lung Cancer (NSCLC)
Figure 31. Global Taletrectinib Adipate Market: Metastatic Non-Small Cell Lung Cancer (NSCLC) (2021-2026) & (Units)
Figure 32. Taletrectinib Adipate Consumed in Others
Figure 33. Global Taletrectinib Adipate Market: Others (2021-2026) & (Units)
Figure 34. Global Taletrectinib Adipate Sale Market Share by Application (2025)
Figure 35. Global Taletrectinib Adipate Revenue Market Share by Application in 2025
Figure 36. Taletrectinib Adipate Sales by Company in 2025 (Units)
Figure 37. Global Taletrectinib Adipate Sales Market Share by Company in 2025
Figure 38. Taletrectinib Adipate Revenue by Company in 2025 ($ millions)
Figure 39. Global Taletrectinib Adipate Revenue Market Share by Company in 2025
Figure 40. Global Taletrectinib Adipate Sales Market Share by Geographic Region (2021-2026)
Figure 41. Global Taletrectinib Adipate Revenue Market Share by Geographic Region in 2025
Figure 42. Americas Taletrectinib Adipate Sales 2021-2026 (Units)
Figure 43. Americas Taletrectinib Adipate Revenue 2021-2026 ($ millions)
Figure 44. APAC Taletrectinib Adipate Sales 2021-2026 (Units)
Figure 45. APAC Taletrectinib Adipate Revenue 2021-2026 ($ millions)
Figure 46. Europe Taletrectinib Adipate Sales 2021-2026 (Units)
Figure 47. Europe Taletrectinib Adipate Revenue 2021-2026 ($ millions)
Figure 48. Middle East & Africa Taletrectinib Adipate Sales 2021-2026 (Units)
Figure 49. Middle East & Africa Taletrectinib Adipate Revenue 2021-2026 ($ millions)
Figure 50. Americas Taletrectinib Adipate Sales Market Share by Country in 2025
Figure 51. Americas Taletrectinib Adipate Revenue Market Share by Country (2021-2026)
Figure 52. Americas Taletrectinib Adipate Sales Market Share by Type (2021-2026)
Figure 53. Americas Taletrectinib Adipate Sales Market Share by Application (2021-2026)
Figure 54. United States Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 55. Canada Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 56. Mexico Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 57. Brazil Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 58. APAC Taletrectinib Adipate Sales Market Share by Region in 2025
Figure 59. APAC Taletrectinib Adipate Revenue Market Share by Region (2021-2026)
Figure 60. APAC Taletrectinib Adipate Sales Market Share by Type (2021-2026)
Figure 61. APAC Taletrectinib Adipate Sales Market Share by Application (2021-2026)
Figure 62. China Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 63. Japan Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 64. South Korea Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 65. Southeast Asia Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 66. India Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 67. Australia Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 68. China Taiwan Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 69. Europe Taletrectinib Adipate Sales Market Share by Country in 2025
Figure 70. Europe Taletrectinib Adipate Revenue Market Share by Country (2021-2026)
Figure 71. Europe Taletrectinib Adipate Sales Market Share by Type (2021-2026)
Figure 72. Europe Taletrectinib Adipate Sales Market Share by Application (2021-2026)
Figure 73. Germany Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 74. France Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 75. UK Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 76. Italy Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 77. Russia Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 78. Middle East & Africa Taletrectinib Adipate Sales Market Share by Country (2021-2026)
Figure 79. Middle East & Africa Taletrectinib Adipate Sales Market Share by Type (2021-2026)
Figure 80. Middle East & Africa Taletrectinib Adipate Sales Market Share by Application (2021-2026)
Figure 81. Egypt Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 82. South Africa Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 83. Israel Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 84. Turkey Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 85. GCC Countries Taletrectinib Adipate Revenue Growth 2021-2026 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of Taletrectinib Adipate in 2026
Figure 87. Manufacturing Process Analysis of Taletrectinib Adipate
Figure 88. Industry Chain Structure of Taletrectinib Adipate
Figure 89. Channels of Distribution
Figure 90. Global Taletrectinib Adipate Sales Market Forecast by Region (2027-2032)
Figure 91. Global Taletrectinib Adipate Revenue Market Share Forecast by Region (2027-2032)
Figure 92. Global Taletrectinib Adipate Sales Market Share Forecast by Type (2027-2032)
Figure 93. Global Taletrectinib Adipate Revenue Market Share Forecast by Type (2027-2032)
Figure 94. Global Taletrectinib Adipate Sales Market Share Forecast by Application (2027-2032)
Figure 95. Global Taletrectinib Adipate Revenue Market Share Forecast by Application (2027-2032)
